Brief: Neopharm changes CEO to Lee Dae Yeol
30/12/2016 03:10
Dec 30 (Reuters) - Neopharm Co Ltd 092730.KQ :
* Says it changes CEO of the co to Lee Dae Yeol from Yoo
Geun Jik on Dec. 30, to improve management efficiency
Source text in Korean: https://goo.gl/e7xgl6
Further company coverage: 092730.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; Reuters Messaging:
Yinglan.Ma@thomsonreuters.com@reuters.net))
Recent news on NeoPharm
See all newsBrief: Neopharm Q4 Operating Profit 7.2 Billion Won, Up 8% From Year Earlier
Brief: Neopharm Q1 Operating Profit 7.8 Billion Won, Up 14.6% From Year Earlier
Brief: Neopharm Q4 Operating Profit 6.7 Billion Won, Down 3.8% From Year Earlier
Brief: Neopharm Q2 Operating Profit 6.1 Billion Won, Down 2.7% From Year Earlier
Brief: Neopharm Q1 Operating Profit 7 Billion Won, Down 3.5% From Year Earlier